Press Release

Myomo, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York

CAMBRIDGE, Mass., September 5, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Chairman and Chief Executive Officer, Paul R. Gudonis, and its Chief Financial Officer, Ralph Goldwasser, will present at the 19th Annual Rodman & Renshaw Global Investment Conference at the Lotte New York Palace Hotel in New…

Read More

Myomo, Inc. Reports Second Quarter 2017 Results

CAMBRIDGE, Mass., August 14, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more.

Read More

Myomo, Inc. to Report Second Quarter 2017 Results on August 14, 2017

Management to hold a conference call at 4:30 p.m. EDT CAMBRIDGE, Mass., August 10th, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its unaudited financial results for the quarter ended June 30, 2017 on Monday, August 14, 2017, after the…

Read More

Myomo, Inc. Obtains CE Mark Approval for MyoPro®

Myomo, Inc. Obtains CE Mark Approval for MyoPro® Enables Company to Start Providing Devices in Europe CAMBRIDGE, Mass., July 31, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis…

Read More

Myomo Expands Management Team

Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis CAMBRIDGE, Mass., July 25, 2017 – Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with three new full-time positions in medical affairs, sales and marketing. The expansion marks the company’s accelerated commercialization of…

Read More

Myomo, Inc. Introduces Center of Excellence Program

Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Nationwide Roster of Top O&P Practices Supports MyoPro® Powered Orthosis Cambridge, MA., July 12, 2017 – Myomo®, Inc. (NSYE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the launch of its Center of Excellence (CoE) program, which recognizes top…

Read More

Myomo, Inc. Announces Publication of Significant Clinical Research

Peer-reviewed Results Indicate Significant Reduction in Upper Extremity Impairment with MyoPro®, with Changes Exceeding Clinically Important Thresholds CAMBRIDGE, Mass., June 27, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced publication of an investigator-led clinical study in the Archives of Physical Medicine and Rehabilitation. The…

Read More

Myomo, Inc. Launches MyoPro® 2

Powered Arm Orthosis Features Interchangeable, Extended-life Rechargeable Batteries Myomo, Inc. (NSYE MKT: MYO) today announced the launch of its next-generation MyoPro® myoelectric arm orthosis (powered brace), the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury,…

Read More

Myomo, Inc. Completes Historic Initial Public Offering

First company to go public on the NYSE MKT under JOBS Act Regulation A+ Cambridge, MA., June 9, 2017 – Myomo, Inc. (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares…

Read More